Q2 2019
Released Aug 7, 2019, before the open
10-Q filed Aug 7, 2019, 38 days after period end · 0001144204-19-038038
Q2 2019 · 10-Q
Revenue$0.00$0.00 — vs Q2 2018no prior Q1 2019 on file
Net Income-$3.43M-$3.43M N/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.14-$0.14 N/M vs Q2 2018N/M vs Q1 2019
Operating Income-$3,350,603N/M
Operating Cash Flowderived-$2,557,928N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$3.43M | -$3.26M | -$6.09M | -$5.76M |
| EPS Diluted | -$0.14 | -$0.15 | -$0.31 | -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR